Two Sigma Securities’s Phio Pharmaceuticals PHIO Stock Holding History
Bought
Maintained
Sold
Other funds holding PHIO
NAMI
XT
Two Sigma Securities's PHIO Position: Q2 2026 in Review
Two Sigma Securities sold out of Phio Pharmaceuticals (PHIO) in Q2 2026, closing a stake of 15,224 shares — an estimated $18.6K sold.
Two Sigma Securities first reported a position in PHIO in Q1 2017 and held it in 15 quarters. The position peaked at $39K in Q2 2021. 24 funds tracked by Wall St. Rank hold PHIO as of Q2 2026.
- Two Sigma Securities reported no remaining Phio Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Two Sigma Securities sold 15,224 Phio Pharmaceuticals shares in Q2 2026, an estimated $18.6K.
- Two Sigma Securities first reported a position in Phio Pharmaceuticals in Q1 2017 and held it in 15 quarters.
- Two Sigma Securities's Phio Pharmaceuticals position peaked at $39K in Q2 2021.
- 24 funds tracked by Wall St. Rank held Phio Pharmaceuticals as of Q2 2026.
Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.